(19)
(11) EP 4 739 303 A2

(12)

(88) Date of publication A3:
17.04.2025

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24836562.9

(22) Date of filing: 03.07.2024
(51) International Patent Classification (IPC): 
A61K 31/335(2006.01)
A61K 31/36(2006.01)
A61K 31/357(2006.01)
A61K 31/33(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/36; A61P 25/26; A61K 45/06; A61K 31/138; A61K 31/4525; A61K 31/135; A61K 31/343
 
C-Sets:
  1. A61K 31/343, A61K 2300/00;
  2. A61K 31/36, A61K 2300/00;
  3. A61K 31/138, A61K 2300/00;
  4. A61K 31/4525, A61K 2300/00;
  5. A61K 31/135, A61K 2300/00;

(86) International application number:
PCT/US2024/036639
(87) International publication number:
WO 2025/010308 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 03.07.2023 US 202363524735 P

(71) Applicant: EmpathBio, Inc.
New York, NY 10119 (US)

(72) Inventors:
  • SHORT, Glenn
    New York, New York 10119 (US)
  • BOWEN, Carrie
    New York, New York 10119 (US)

(74) Representative: Smart, Jessica Ann et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) MDMA ENANTIOMER COMPOSITIONS AND METHODS FOR MODULATING AGGRESSION RESPONSE